Cell and Gene Therapy
Home / Cell and Gene Therapy
Engineering Tomorrow’s Medicine Today
Partnering with sponsors to pioneer cell and gene therapies that transform rare diseases, redefine oncology, and unlock the future of personalized care.
Vision for Cell & Gene Therapy
Cell and gene therapies represent one of the fastest evolving areas of medicine, requiring specialized scientific expertise, complex manufacturing strategies, adaptive clinical development, and evolving regulatory pathways.
Novaspire partners with innovators to navigate these challenges and efficiently advance transformative therapies from early development through commercialization.
Our Expertise
Cell & Gene Therapy Development Strategy
Translational Science & Biomarker Development
ATMP Regulatory Strategy
Clinical Operations & Long-Term Follow-up
CMC, Manufacturing & Supply Chain Consulting
Hallmarks of Our Pharmacovigilance Solutions
We focus on assessing and enhancing the risk-benefit profiles of products, safeguarding patient safety while maximizing market potential.
By leveraging advanced tools and analytics, we streamline processes like case management, signal detection, and reporting for optimal efficiency.
Why Choose Us
Advanced Therapy Expertise
Scientific guidance across autologous, allogeneic, gene editing, RNA, and cell therapy platforms.
Integrated Development
Coordinated support spanning discovery, CMC, clinical development, regulatory strategy, and commercialization.
Global Execution
Specialized operational frameworks for complex multinational advanced therapy programs.
Pharmacovigilance Related Blogs
Therapeutic Expertise
Therapeutic Areas
- Immuno mediated inflammatory Disease
- Oncology
- Hematology
- Neurology
- Metabolic
- Cardiovascular
Modalities We Support:
- Gene Modified Cell Therapy
- Gene Therapy
- Call Therapy
- RNA Therapy
- Gene Editing
- apies
Speak to an Expert















